Key wor&v Carotid body: Arterial chemoreceptor; Prostaglandin E.; Acetylsalicylic acid: lndomethacin Salicylates, at the high therapeutic doses used in the treatment of rheumatoid arthritis, produce an increase in ventilation and augment the carotid body reactivity to hypoxic stimulus, leading to an exaggerated hyperventilation during hypoxia. These effects had been related to the action of salicylates as uncouplers of oxidative phosphorylation. In the present study, carried out in an in vitro preparation of the rabbit carotid body, we show that acetylsalicylic acid and indomethacin, two anti-inflammatory drugs that are also powerful inhibitors of cyclooxygenase, the prostaglandinsynthetizing enzyme, produce an increase in the [3H]catecholamine release evoked by low oxygen stimulation. The drugs did not affect basal normoxic release, a finding that suggests that at the concentration used these anti-inflammatory agents do not have uncoupling actions, and that their effects on hypoxic-induced release of [3H]catecholamines is mediated by their specific action as cyclooxygenase inhibitors. In agreement with this suggestion we found that prostaglandin E~ completely prevented the effects of both anti-inflammatory agents. In addition, our data indicate that endogenously synt hetized prostaglandins are powerful modulators of chemoreceptor cell function.
Salicylates at high doses stimulate ventilation, the effect being mediated by peripheral and central chemoreceptors [6] , It has been reported also that salicylates potentiate the carotid body-mediated hyperventilation produced by hypoxia in man [10] . The mechanism of action of salicylates at the carotid body (CB) level has been related to their well known respiratory uncoupling effect [3, 61. On the other hand, it is well known also that salicylates are potent and irreversible inhibitors of cyclooxygenase, an enzyme involved in the synthesis of prostaglandins [4] . Since it has been reported [5] that prostaglandin E2 in vivo inhibits ongoing chemoreceptor discharges in the carotid sinus nerve, we have tested the possibility that at least part of the CB-mediated effects of salicylate on ventilation could be produced by a specific effect of the antiinflammatory drugs by inhibiting prostaglandin synthesis. Taking into consideration that all chemostimulant agents tested increase in parallel the action potential frequency in the carotid sinus nerve and the release of catecholamines (CAs) from chemoreceptor cells [ have measured the release of catecholamines as an index of the CB chemoreceptors activation.
The experiments were performed in CBs isolated from adult New Zealand rabbits anesthetized with sodium pentobarbital (30-40 mg/kg, Sigma) administered via the lateral vein of the ear. After tracheostomy, the bifurcation of the carotid artery was dissected, removed as a block and placed in a Lucite chamber filled with ice-cold saline. The CBs were identified and cleaned of surrounding connective tissues under a dissecting scope. Thereafter the catecholamine deposits of the CBs were labeled by incubating the organs with the labeled natural precursor [3H]tyrosine as previously described [11] . After this loading incubation, the CBs were incubated in precursor-free solution for 2 h (solution renewal every 30 min), and finally the collection of the incubating media for analysis in their [3H]CA content was started (see Fig. 1 for protocol of sample collection). The isolation and quantification of [3H]CA in the collected media and in the CB at the end of the release experiments was performed as previously described [11] . The incubating solution in these experiments was a COjHCO3-buffered saline with the following composition (in mM): NaCI 116, KC1 5, CaCI, 2, MgC12 1.1, NaHCO3 24, HEPES 10, glucose 5.5. The solutions were equilibrated with a 5% CO2-containing gas mixture (see results) and adjusted, if needed, at a pH CA from a CB (control) incubated with a 20% 02/5% CO2-equilibrated solution (empty bars), and subjected to two periods of 10 min of hypoxic stimulation (incubation in a solution equilibrated with 5% 02/ 5% CO> filled bars). B: another CB (experimental) was similarly incubated but the 10 min period prior to and during the second hypoxic stimulation the incubating solutions contained 100/IM of acetylsalicylic acid (ASA). C shows the evoked release (cpm above the horizontal lines throughout the bars), expressed as percent of [3H]CA tissue content, for both presentations of the stimulus ($1 and $2) and for control and experimental CBs. D shows the ratios of the evoked release in the second stimulus to that in the first stimulus ($2/S, ratios) for control and experimental CBs.
of 7.40. Statistical significance of the differences observed was assessed by using a t-test for unpaired data. Fig. 1 shows the release of [3H]CA from a pair of CBs subjected to two consecutive hypoxic stimulations (incubation for 10 min in a 5% 02/5% CO2 rest N2-equilibrated solution; filled bars). In the experimental CB (Fig.  1B) , the 10 min prior to and during the second presentation of the stimulus the solution contained 100 ~tM of acetylsalicylic acid. It is evident that acetylsalicylic acid potentiates low oxygen-induced release of [3H]CA. The effect of the drug at this concentration on the basal normoxic release (20% 02/5% CO2-equilibrated solutions) was somewhat variable. In some experiments we observed a moderate increase in the basal release while in others (like the one in the figure) there was not any significant effect. No effect on the basal release was observed with lower concentrations of acetylsalicylic acid (20/IM), Fig. 1C shows the stimulus-induced release (above horizontal lines in A and B) for control and experimental CBs and for both presentations of the stimuli, S~ and S> respectively, expressed as percent of endogenous [3H]CA content. In Fig. 1D are represented the SJS~ ratios of the [3H]CA-induced release for both CBs. This form of pre- senting the data eliminates individual variations in the absolute amounts of the evoked release and allows a better dissection of the effects of the drug. In this particular experiment acetylsalicylic acid raised the SJS, ratio to 350% of that seen in the control CB, The rest of the experiments to be presented were performed following this protocol. At the concentrations used, neither acetylsalicylic acid nor indomethacin have effect as uncouplers of oxidative phosphorylation [3] , but they inhibit markedly cyclooxygenase, the prostaglandin-synthesizing enzyme [4] . Therefore we tested for the reversibility of the effects produced by both agents by the addition of prostaglandin E 2. We chose this particular prostaglandin because it is known that it inhibits the stimulus-induced release of CA in different catecholaminergic structures and in different species including the rabbit [12] . Table I shows that 300 nM of prostaglandin Ez applied simultaneously with indomethacin completely reversed the effect of the latter agent. The same reversibility was observed for the acetylsalicylic acid effect (not shown). Prostaglandin E z, at these concentrations, did not modify the basal release of [3H]CA. The present results show that acetylsalicylic acid and indomethacin potentiated low pO2-induced release of [3H]CA without affecting the basal release. This effect is completely reversed by simultaneous application of prostaglandin E2, suggesting that the actions of these anti-inflammatory drugs are not the result of their uncoupling properties, but produced via inhibition of cyclooxygenase with the subsequent decrease in endogenous prostaglandin production. Supporting this interpretation, we have found that average prostaglandin E2 released to the incubating medium from 7 pairs of CBs was 134.5 + 46.9 pmol/mg prot. in basal normoxic conditions (20% O~/5% CO2), and 198.7 _+ 62.0 in hypoxic conditions (7% 02/5% CO2) (P<0.02). In two additional CBs incubated in the presence of indomethacin, prostaglandin E, release was halved in normoxia and the hypoxia-induced release was abolished.
These data show, for the first time, that prostaglandins are modulators of chemoreceptor cell function and suggest that, at least in part, the inhibitory actions ofprostaglandin E, on carotid sinus nerve activity observed by Belmonte and McQueen [5] were mediated via chemoreceptor cells and not solely mediated by changes in the CB blood flow. It should be mentioned, however, that in the same article these authors reported that, contrary to the in vivo situation, in the vascularly isolated CB preparation when the spontaneous activity in the carotid sinus nerve was low, prostaglandin E~ did not have any effect. This latest finding is in agreement with the observation on the lack ot" effect of prostaglandin E, on the basal release in different preparations, including ours, in which this prostaglandin inhibits the stimulus-induced release [2, 121.
Regarding the mechanism of action of salicylates on the production ofhyperventilation, it will appear that the rapid hyperventilation observed immediately (within 1 min) after a high dose of the drug [6] could in fact be due to an uncoupling effect, but the long lasting hyperreactivity to hypoxia [10] can be adequately explained on the basis of our findings. Thus, an inhibition of prostaglandin synthesis will, on the arrival of a hypoxic stimulus, lead to an exaggerated release of catecholamines (and probably of other neurotransmitters) and a concurrent exaggerated activity in the carotid sinus nerve and ventilatory response.
The mechanism by which prostaglandin E 2 produces its inhibitory effect remains to be established. Due to the fact that it only affects the stimulus-induced release, and that the effect can be at least partially abolished by increasing the extracellular concentration of Ca > [12] , it is tempting to suggest that prostaglandins interfere with the stimulus-activated influx of Ca > into chemoreceptor cells.
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